25 Participants Needed

Neuromodulation for Spinal Cord Injury

DC
MM
Overseen ByMatija Milosevic, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this research is to explore the effect of magnetic stimulation to activate the brain, electrical spinal cord stimulation to activate spinal cord, and electrical muscle stimulation used to activate upper limb (arms), lower limb (legs) and trunk (stomach) muscles in people with spinal cord injury (SCI) and able-bodied subjects (without SCI).

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on investigational drugs or any intervention that affects neuromotor function, you may not be eligible to participate.

What data supports the effectiveness of the treatment Repetitive Synchronized Associative Stimulation Neuromodulation for spinal cord injury?

Research shows that paired associative stimulation (PAS), a component of the treatment, can improve hand function and reduce pain in patients with spinal cord injuries. It works by strengthening nerve connections in the spinal cord, which may help with motor rehabilitation and pain relief.12345

Is neuromodulation for spinal cord injury safe for humans?

Paired associative stimulation (PAS), a type of neuromodulation, is generally considered safe with rare cases of adverse effects reported in patients with spinal cord injuries.13678

How is Repetitive Synchronized Associative Stimulation Neuromodulation different from other treatments for spinal cord injury?

This treatment is unique because it uses a non-invasive method called paired associative stimulation (PAS), which combines brain and nerve stimulation to strengthen neural connections and improve motor function in spinal cord injury patients. Unlike other treatments, PAS can lead to long-lasting improvements in voluntary movement and pain relief without the need for drugs.13679

Research Team

MM

Matija Milosevic, PhD

Principal Investigator

University of Miami

Eligibility Criteria

This trial is for individuals with spinal cord injuries and also includes able-bodied participants. The study aims to understand the effects of different types of stimulation on brain, spinal cord, and muscle activity.

Inclusion Criteria

I am physically able.
I can still move or feel my lower-limb muscles on at least one side.
My trunk muscles show activity when tested with special equipment.
See 4 more

Exclusion Criteria

I have nerve damage, including from diabetes or trapped nerves.
I am not on any experimental drugs affecting movement.
I have a history of epilepsy or seizures.
See 14 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive magnetic stimulation to activate the brain, electrical spinal cord stimulation, and electrical muscle stimulation for up to 2 months

8 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Repetitive Synchronized Associative Stimulation Neuromodulation
Trial Overview The trial tests magnetic brain stimulation (iTBS), electrical spinal cord stimulation (TSCS), and muscle activation via functional electrical stimulation (FES). A sham iTBS serves as a control to compare against real treatments.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Upper-limb (arms) target groupExperimental Treatment4 Interventions
Quadriplegic individuals with SCI who are primary non-ambulatory (walking) will be in this group for up to 2 months.
Group II: Trunk (torso) target groupExperimental Treatment4 Interventions
Quadriplegic or paraplegic individuals with SCI who are primary wheelchair users will be in this group for up to 2 months.
Group III: Lower-limb (legs) target groupExperimental Treatment4 Interventions
Quadriplegic or paraplegic individuals with SCI primary who can walk will be in this group for up to 2 months.
Group IV: Able-bodied target groupActive Control4 Interventions
Individuals with no spinal cord injury will be in this group for up to 2 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

Findings from Research

Long-term paired associative stimulation (PAS) was found to be a safe and effective treatment for improving hand motor function in five patients with non-traumatic tetraplegia, with significant improvements observed in manual muscle testing and other functional assessments over a 6-week period and follow-ups.
All patients showed consistent improvements in muscle strength and hand function, with a mean increase of 1.44 points in manual muscle testing immediately after PAS and sustained improvements at 1 and 6 months post-treatment.
Paired associative stimulation improves hand function after non-traumatic spinal cord injury: A case series.Tolmacheva, A., Savolainen, S., Kirveskari, E., et al.[2022]
A 47-year-old man with incomplete paraplegia showed significant improvement in mobility after receiving paired associative stimulation (PAS) for 6 months, enabling him to stand and walk independently with a rollator, which he could not do before treatment.
The study indicates that PAS, combining transcranial magnetic stimulation and peripheral nerve stimulation, can effectively promote walking rehabilitation in paraplegic patients without any adverse effects, suggesting its potential as a therapeutic intervention.
Enabling and promoting walking rehabilitation by paired associative stimulation after incomplete paraplegia: a case report.Shulga, A., Savolainen, S., Kirveskari, E., et al.[2021]
Paired associative stimulation (PAS) showed promising results in reducing severe drug-resistant neuropathic pain in a 50-year-old man with spinal cord injury, with pain scores decreasing by 44% after two weeks of therapy.
The therapy not only alleviated pain but also improved hand motor function and quality of sleep, suggesting that PAS may modulate pain pathways at the spinal cord level and could be a valuable adjunct treatment for neuropathic pain following spinal cord injury.
Analgesic effect of paired associative stimulation in a tetraplegic patient with severe drug-resistant neuropathic pain: a case report.Vaalto, S., Nyman, AL., Shulga, A.[2021]

References

Paired associative stimulation improves hand function after non-traumatic spinal cord injury: A case series. [2022]
Enabling and promoting walking rehabilitation by paired associative stimulation after incomplete paraplegia: a case report. [2021]
Analgesic effect of paired associative stimulation in a tetraplegic patient with severe drug-resistant neuropathic pain: a case report. [2021]
The use of F-response in defining interstimulus intervals appropriate for LTP-like plasticity induction in lower limb spinal paired associative stimulation. [2015]
Failure of spinal paired associative stimulation to induce neuroplasticity in the human corticospinal tract. [2021]
Spinal Cord Injury: Lessons about Neuroplasticity from Paired Associative Stimulation. [2021]
A novel paired associative stimulation protocol with a high-frequency peripheral component: A review on results in spinal cord injury rehabilitation. [2021]
Optimal peripheral nerve stimulation intensity for paired associative stimulation with high-frequency peripheral component in healthy subjects. [2022]
Long-term paired associative stimulation can restore voluntary control over paralyzed muscles in incomplete chronic spinal cord injury patients. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security